Findings

What do systematic reviews say?

24 questions · 24 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 7 · 29.2%GRADE not reported 0 · 0%Very low 13 · 54.2%Low 4 · 16.7%Moderate 0 · 0%High 0 · 0%

FLUPHENAZINE DECANAOTE vs FLUPHENAZINE ENANTHATE

Hospital admission ‐ not reported · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Fluphenazine decanoate (depot) and enanthate for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

FLUPHENAZINE DECANAOTE vs FLUPHENAZINE ENANTHATE

Leaving the study early · patients with schizophrenia

It is very uncertain whether FLUPHENAZINE DECANAOTE changes leaving the study early compared with FLUPHENAZINE ENANTHATE (very low certainty).

1 finding from 1 review

Fluphenazine decanoate (depot) and enanthate for schizophrenia 2015 · Cochrane Headline outcomes only
RR 2.43 [0.71, 8.32]
1 study · 49 participants
Very low

FLUPHENAZINE DECANAOTE vs FLUPHENAZINE ENANTHATE

Mental state · patients with schizophrenia

1 finding from 1 review

Fluphenazine decanoate (depot) and enanthate for schizophrenia 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 39 participants
Very low

FLUPHENAZINE DECANAOTE vs FLUPHENAZINE ENANTHATE

Adverse effects/events ‐ extrapyramidal symptoms ‐ medium term Number of instances of extrapyramidal symptoms · patients with schizophrenia

It is very uncertain whether FLUPHENAZINE DECANAOTE changes extrapyramidal adverse effects ‐ general compared with FLUPHENAZINE ENANTHATE (very low certainty).

1 finding from 1 review

Fluphenazine decanoate (depot) and enanthate for schizophrenia 2015 · Cochrane Headline outcomes only
RR 1.14 [0.79, 1.64]
2 studies · 49 participants
Very low